Trademarkia Logo

Canada

C$
TWINSTRAND
SEARCHED

on 6 Jun 2025

Last Applicant/ Owned by

TwinStrand Biosciences, Inc.

Suite 7503131 Elliott AvenueSeattle, WA 98121

US

Serial Number

1952233 filed on 19th Mar 2019

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

TWINSTRAND

Trademark usage description

kits comprising primarily of reagents, enzymes and nucleotides for human identification and genetic and forensic medical-scientific research use; reag Read More

Classification Information


Class [001]
Kits comprising primarily of reagents, enzymes and nucleotides for human identification and genetic and forensic medical-scientific research use; reagents, enzymes, and nucleotides for medical-scientific research use; reagents, enzymes, and nucleotides for nucleic acid sequencing for medical-scientific research use; reagents for scientific or medical use, namely, reagents for use in preparation of DNA sequencing samples


Classification kind code

12

Class [005]
Medical diagnostic reagents; clinical diagnostic reagents; diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in genetic and oncology disease testing; medical diagnostic assays for medical and diagnostic purposes for testing of bodily samples for detecting autoimmune diseases, for detecting infections, and for detecting cancer; medical diagnostic reagents and assays for testing body fluids; enzyme diagnostic preparations for in vitro testing for medical use; in-vivo diagnostic agents, namely, biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes


Classification kind code

12

Class [009]
Computer software for scientific and medical analysis of genetic sequences; computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, medical research, clinical research, molecular pathology, molecular diagnostics, biotechnology, oncology, genetics, pharmacology, forensics, genotoxicity, carcinogenesis, and consumer genomics; computer software for receiving, processing, transmitting and displaying data for use in genetic analysis


Classification kind code

12

Class [042]
Nucleic acid sequencing and analysis services for scientific research purposes; genome sequencing and analysis services for scientific research purposes; genetic analysis and reporting services for scientific research purposes; genome sequencing and analysis services for forensic purposes; genome sequencing and analysis services for genotoxicity purposes; structural and functional analysis of genomes; medical and scientific research in the field of cancer detection, diagnosis and monitoring; providing medical-scientific research information in the fields of pharmaceuticals and genetics; pharmaceutical research and development services; providing temporary use of non-downloadable computer software for scientific and medical analysis of genetic sequences; providing temporary use of non-downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnostics, medical research, clinical research, molecular pathology, molecular diagnostics, biotechnology, oncology, genetics, pharmacology, forensics, genotoxicity, carcinogenesis, and consumer genomics


Classification kind code

12

Class [044]
Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; consulting and testing services in the field of genetic sequencing for medical, diagnostic and treatment purposes; providing genomics testing and reporting services in the field of biomarkers for the susceptibility, risk, diagnosis, prognosis, treatment or management of cancer; providing medical information regarding genetics for educational purposes via a website


Classification kind code

12

Mark Details


Serial Number

1952233

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 26
on 6th Jun 2025
Approved
Submitted for opposition 27
on 6th Jun 2025
Approval Notice Sent
Submitted for opposition 15
on 6th Sept 2024
Correspondence Created
Submitted for opposition 12
on 7th Dec 2023
Extension of Time
Submitted for opposition 22
on 17th May 2023
Search Recorded
Submitted for opposition 20
on 17th May 2023
Examiner's First Report
Submitted for opposition 287
on 28th Mar 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 22nd Mar 2019
Formalized
Submitted for opposition 30
on 19th Mar 2019
Filed
Submitted for opposition 1
on 19th Mar 2019
Created